3

OWNERSHIP DOCUMENT

Company: ZyVersa Therapeutics, Inc.
Filed: December 20, 2021
Period of Report: December 20, 2021
Accession Number: 0001213900-21-066469

View Document ↗ View on SEC.gov ↗